John L. Lamattina - Jun 16, 2022 Form 4 Insider Report for Immunome Inc. (IMNM)

Role
Director
Signature
/s/ Purnanand D. Sarma, Attorney-in-Fact
Stock symbol
IMNM
Transactions as of
Jun 16, 2022
Transactions value $
$0
Form type
4
Date filed
6/21/2022, 06:01 PM
Previous filing
Jun 13, 2022
Next filing
Dec 27, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMNM Stock Option (Right to Buy) Award $0 +6.5K $0.00 6.5K Jun 16, 2022 Common Stock 6.5K $2.62 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the options shall vest 25% every quarter after the grant date.